News
MedPage Today on MSN3d
Should AMA 'Support' a Registry to Track Side Effects of GLP-1 Drugs?CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback